Physician profile
Duane Nolff
NPI 1881675031
$1,341.98
in general payments reported to CMS, 2019-2025
13 companies · $153 in 2025
The $153 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $125 · 2022: $115 · 2023: $569 · 2024: $381 · 2025: $153.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,082 · Education: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,081.82 |
| Education | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $319.02 | 2023-2025 | |
| Gilead Sciences, INC. | $170.96 | 2023 | Epclusa |
| Astrazeneca Pharmaceuticals LP | $155.27 | 2022-2024 | Fasenra |
| Uswm, LLC | $142.13 | 2023-2024 | Lucemyra |
| Abbott Laboratories | $138.86 | 2021-2023 | Gallant |
| Axsome Therapeutics, INC. | $124.74 | 2024 | Sunosi |
| Janssen Pharmaceuticals, INC | $91.81 | 2021-2022 | |
| Braeburn INC. | $75.89 | 2023-2025 | Brixadi |
| Indivior INC. | $51.16 | 2023-2024 | Sublocade |
| Csl Behring | $20.00 | 2024 | Kcentra |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $19.74 | 2022 | |
| Orexo US, INC. | $17.17 | 2025 | Zubsolv |
| Vanda Pharmaceuticals INC. | $15.23 | 2025 | Fanapt |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Duane Nolff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.